A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo
Consortia: CMAI
Verma MK, Clemens J, Burzenski L, Sampson SB, Brehm MA, Greiner DL, Shultz LD.
J Immunol Methods. 2017 Apr 5. pii: S0022-1759(16)30346-5. doi: 10.1016/j.jim.2017.03.021. Epub 2017 Apr 6. PMID: 28390927